2013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals.
about
Arm position during ambulatory blood pressure monitoring: a review of the evidence and clinical guidelinesNovel Approaches to Investigate One-Carbon Metabolism and Related B-Vitamins in Blood Pressure[Practice of ambulatory measurement of arterial pressure in Brazzaville (Congo): preliminary data]Validation of the integration of technology that measures additional "vascular" indices into an ambulatory blood pressure monitoring systemClinical implications of the 2013 ESH/ESC hypertension guidelines: targets, choice of therapy, and blood pressure monitoringCurrent issues in the management and monitoring of hypertension in chronic kidney disease.Chronic aerobic exercise improves blood pressure dipping status in African American nondippers.Is isolated systolic hypertension an indication for renal denervation?Optimising the accuracy of blood pressure monitoring in chronic kidney disease: the utility of BpTRUEthical complexities in standard of care randomized trials: A case study of morning versus nighttime dosing of blood pressure drugsAssociations between cystatin C-based eGFR, ambulatory blood pressure parameters, and in-clinic versus ambulatory blood pressure agreement in older community-living adultsCan Ambulatory Blood Pressure Variability Contribute to Individual Cardiovascular Risk Stratification?Ambulatory blood pressure monitoring in clinical practice: a review.Chinese herbal medicine qi ju di huang wan for the treatment of essential hypertension: a systematic review of randomized controlled trials.Ambulatory Blood Pressure Monitoring: Five Decades of More Light and Less Shadows.Exploring diurnal variation using piecewise linear splines: an example using blood pressure.Chronotherapy improves blood pressure control and reduces vascular risk in CKD.Influences of the circadian clock on neuronal susceptibility to excitotoxicity.Chronotherapeutics of conventional blood pressure-lowering medications: simple, low-cost means of improving management and treatment outcomes of hypertensive-related disorders.Sleep-time ambulatory blood pressure as a novel therapeutic target for cardiovascular risk reduction.Around-the-clock ambulatory blood pressure monitoring is required to properly diagnose resistant hypertension and assess associated vascular risk.Current therapeutic approaches to cardio-protection in hypertension.Treatment of hypertension with chronotherapy: is it time of drug administration?Clinical value of ambulatory blood pressure: Is it time to recommend for all patients with hypertension?The use of ambulatory blood pressure measurement.Secondary Stroke Prevention: Improving Diagnosis and Management with Newer Technologies.Ambulatory Blood Pressure Monitoring in the Diagnosis and Treatment of Hypertension.Multidisciplinary Approach in the Treatment of Resistant Hypertension.Prevalence, determinants, and clinical significance of masked hypertension and white-coat hypertension in patients with chronic kidney disease.Bedtime ingestion of hypertension medications reduces the risk of new-onset type 2 diabetes: a randomised controlled trial.Differences in 24-h blood pressure profile of Japanese hypertensive patients under ARB treatment.The relationship between AASI and arterial atherosclerosis in ESRD patients.Period3 VNTR polymorphism influences the time-of-day pain onset of acute myocardial infarction with ST elevation.Between-person and within-person approaches to the prediction of ambulatory blood pressure: the role of affective valence and intensity.Scaling up the use of home blood pressure monitoring in the management of hypertension in low-income countries: A step towards curbing the burden of hypertension.Circadian disruption: New clinical perspective of disease pathology and basis for chronotherapeutic intervention.Morning surge in blood pressure using a random-effects multiple-component cosinor model.Sleep-Time Ambulatory BP Is an Independent Prognostic Marker of CKD.Chronotherapy with conventional blood pressure medications improves management of hypertension and reduces cardiovascular and stroke risks.Elevated asleep BP as predictor of type 2 diabetes and therapeutic target for prevention.
P2860
Q26851169-6A56F84C-77B0-4957-B2F2-91EF44723559Q28074234-0C00FE83-C602-478C-A0AA-AF21C1E52D76Q30980464-9083649F-FFF1-46A9-A7F8-AE505D22969CQ33583534-9D04965E-BD5C-4D9B-8154-3881ED620C6BQ33804805-CBA5989F-2382-43F5-8004-B5F29B925A01Q33858915-D2B3D79D-AC25-48DC-B3D2-6976D7C06429Q34588702-25D7AD72-6231-4C4B-A750-EC29CCE6B812Q34741238-AF01E243-3356-448D-8CF1-0738E841BCC8Q35013404-11C6113D-B1B6-4ECC-BA8B-5917CD1CC237Q36275898-468314F5-43C4-4332-845B-955A3713B4AAQ36664971-8F1367A2-0A5D-42ED-AC35-090C5A9A445EQ36924802-8741B492-A177-4AD2-B27D-0D75C5F7C5E6Q36928328-A66EEDFD-9CA1-44FB-A315-459741C7DA40Q37002889-CEE9A249-D8D0-41C2-8C90-5AC3EF205E6EQ37083220-65D5C1D6-370C-4299-B8A9-A4AC58E37A2AQ37622953-AED54BFF-C4AB-4F81-A530-F1508337DF9CQ38100986-C3720B9C-3144-4178-A41E-4EB3D215B134Q38160842-67B74BEC-3134-48F2-AD3A-1A94A09E106DQ38177166-FEBDEC47-816A-48E5-83C6-619AEBAA0A73Q38185598-581B1104-A3D2-4015-8840-E7F682EE8927Q38208966-597B0B2C-C266-4781-9380-1F07D8771490Q38223595-B1E8030D-6928-4433-A5A6-CB9D8732FF2AQ38291112-AA31F68B-8334-48A5-8C88-A431A9D06826Q38614081-1070F739-6FCF-4A65-91CA-D85BC8276F19Q38628834-7E6F37B6-F730-49A4-9F07-F45797284973Q38944341-5EE2DCF8-4748-42F4-B149-8BD01B200906Q39040847-5577B1E8-30E0-4BAF-9F99-F9CFF1FA22CAQ39129288-5E263A21-003E-415A-8A04-9AB6ED01CA95Q40322846-D0C1FCC4-14C3-4A32-8350-2636B81BE51FQ41328936-786DB12F-7437-483D-B05E-823A12F9A8D5Q41727306-B14187F9-AB29-49A5-AFE8-0916D1F25561Q43962249-B08D1CB1-7754-4952-9148-80357FBC70E0Q44060571-3E734A86-DA09-416F-9F60-4C1168C3D960Q46284138-3C3E39EC-D844-442D-B8F4-4E3F5D661C09Q46723017-51909867-E63A-404C-97C0-5B8038D3D92BQ47419916-C5A1D764-7A02-4CB3-A6B7-62E00AA84657Q47554984-1CF6171C-70D5-4F41-A1D0-3B0BF25F5D34Q47736556-4CE24842-803D-486E-B115-DF54284A9717Q47910182-BEECE4F1-BCB2-4253-9ECE-617A442CA1F8Q47911570-383310A7-9EA4-4CDA-A844-8F62C87982E7
P2860
2013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
2013 ambulatory blood pressure ...... tainment of therapeutic goals.
@en
2013 ambulatory blood pressure ...... tainment of therapeutic goals.
@nl
type
label
2013 ambulatory blood pressure ...... tainment of therapeutic goals.
@en
2013 ambulatory blood pressure ...... tainment of therapeutic goals.
@nl
prefLabel
2013 ambulatory blood pressure ...... tainment of therapeutic goals.
@en
2013 ambulatory blood pressure ...... tainment of therapeutic goals.
@nl
P2093
P2860
P921
P1476
2013 ambulatory blood pressure ...... tainment of therapeutic goals.
@en
P2093
American Association of Medical Chronobiology and Chronotherapeutics
Diana E Ayala
International Society for Chronobiology
Michael H Smolensky
Ramón C Hermida
Romanian Society of Internal Medicine
Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk
Spanish Society of Atherosclerosis
P2860
P304
P356
10.3109/07420528.2013.750490
P407
P577
2013-04-01T00:00:00Z